Learning, memory deficits, and impaired neuronal maturation attributed to acrylamide

Area of Science:

• Neuroscience
• Toxicology
• Developmental Biology

Background:

• Acrylamide (ACR) is a known neurotoxin.
• High-dose ACR impairs hippocampal neurogenesis and increases neural progenitor cell death.
• The effects of low-dose ACR on adult neurogenesis and cognition are not well understood.

Purpose of the Study:

• To investigate the effects of environmentally relevant low doses of ACR on mouse hippocampal neurogenesis and neurocognitive functions.
• To determine if ACR exposure impacts learning, memory, neuroinflammation, or neuronal loss.

Main Methods:

• Male C57BL/6 mice were administered vehicle or ACR (2, 20, or 200 μg/kg/day) orally for 4 weeks.
• Hippocampal neurogenesis, neuroinflammation, and neuronal loss were assessed.
• Behavioral studies evaluated learning and memory.
• Primary cultured neurons were incubated with ACR during development.

Main Results:

• ACR exposure did not significantly alter hippocampal neurogenesis, neuroinflammation, or neuronal loss.
• Behavioral tests revealed learning and memory impairment in mice exposed to 200 μg/kg ACR.
• In vitro studies showed ACR delayed neuronal maturation without affecting cell viability.

Conclusions:

• Subchronic low-dose ACR exposure in vivo did not markedly affect hippocampal neurogenesis.
• Higher doses of ACR (200 μg/kg) induced learning and memory deficits in mice.
• In vitro findings suggest ACR may possess developmental neurotoxicity, impacting neuronal maturation and potentially leading to cognitive impairment.